DURVALUMAB
Clinical trials for DURVALUMAB explained in plain language.
Never miss a new study
Get alerted when new DURVALUMAB trials appear
Sign up with your email to follow new studies for DURVALUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for Hard-to-Treat liver cancer
Disease control Recruiting nowThis study tests a new treatment for people with advanced liver cancer that cannot be removed by surgery. It combines precise proton radiation with two immunotherapy drugs (tremelimumab and durvalumab) to boost the immune system's attack on the tumor. About 45 participants will r…
Matched conditions: DURVALUMAB
Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated May 26, 2026 11:56 UTC
-
New triple therapy aims to shrink hard-to-treat liver cancer
Disease control Recruiting nowThis study tests a new first-line treatment for people with advanced intrahepatic cholangiocarcinoma, a type of bile duct cancer that cannot be removed by surgery. The treatment combines chemotherapy directly into the liver artery (HAIC) with two drugs: durvalumab (an immunothera…
Matched conditions: DURVALUMAB
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 26, 2026 11:08 UTC